These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 18021253

  • 1. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
    Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND.
    FEBS J; 2007 Dec; 274(24):6365-77. PubMed ID: 18021253
    [Abstract] [Full Text] [Related]

  • 2. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.
    Br J Cancer; 2007 Jun 18; 96(12):1888-95. PubMed ID: 17505508
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec 18; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

  • 4. Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis.
    Miyata Y, Koga S, Takehara K, Kanetake H, Kanda S.
    Clin Cancer Res; 2003 May 18; 9(5):1734-40. PubMed ID: 12738728
    [Abstract] [Full Text] [Related]

  • 5. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
    Heuser M, Schlott T, Schally AV, Kahler E, Schliephake R, Laabs SO, Hemmerlein B.
    J Urol; 2005 Jun 18; 173(6):2154-9. PubMed ID: 15879878
    [Abstract] [Full Text] [Related]

  • 6. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R, Weiler C, Spring O, Eder M, Buchner A, Popp T, Castro M, Kammerer R, Takikawa O, Hatz RA, Stief CG, Hofstetter A, Zimmermann W.
    Clin Cancer Res; 2007 Dec 01; 13(23):6993-7002. PubMed ID: 18056175
    [Abstract] [Full Text] [Related]

  • 7. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
    Edeline J, Mottier S, Vigneau C, Jouan F, Perrin C, Zerrouki S, Fergelot P, Patard JJ, Rioux-Leclercq N.
    Hum Pathol; 2012 Nov 01; 43(11):1982-90. PubMed ID: 22626276
    [Abstract] [Full Text] [Related]

  • 8. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J, Mourah S, Murata H, Mounier N, Pisonero H, Mongiat-Artus P, Teillac P, Calvo F, Janin A, Dosquet C.
    Cancer; 2008 Jan 15; 112(2):433-42. PubMed ID: 18041056
    [Abstract] [Full Text] [Related]

  • 9. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M, Filleur S, Fournier P, Merle C, Guglielmi J, Courtin A, Degeorges A, Serre CM, Bouvier R, Clézardin P, Cabon F.
    Cancer Res; 2005 Jan 01; 65(1):300-8. PubMed ID: 15665307
    [Abstract] [Full Text] [Related]

  • 10. Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma.
    Sasamura H, Takahashi A, Yuan J, Kitamura H, Masumori N, Miyao N, Itoh N, Tsukamoto T.
    Urology; 2004 Aug 01; 64(2):389-93. PubMed ID: 15302513
    [Abstract] [Full Text] [Related]

  • 11. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
    Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, Harel-Bellan A, Clézardin P, Cabon F.
    Cancer Res; 2003 Jul 15; 63(14):3919-22. PubMed ID: 12873985
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
    Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT.
    Cancer Res; 2008 Jan 01; 68(1):81-8. PubMed ID: 18172299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
    Isenberg JS, Calzada MJ, Zhou L, Guo N, Lawler J, Wang XQ, Frazier WA, Roberts DD.
    Matrix Biol; 2005 Apr 01; 24(2):110-23. PubMed ID: 15890262
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.
    Eur Urol; 2009 Feb 01; 55(2):441-9. PubMed ID: 18395325
    [Abstract] [Full Text] [Related]

  • 20. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages.
    Toge H, Inagaki T, Kojimoto Y, Shinka T, Hara I.
    Int J Urol; 2009 Oct 01; 16(10):801-7. PubMed ID: 19811548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.